Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
not approved Tirzepatide (Zepbound) Approved (Zepbound, Mounjaro) Semaglutide alone (Wegovy) Approved (Wegovy, Ozempic) Cagrilintide alone Investigational Feature Head-to-head data CagriSema Did not meet non-inferiority vs tirzepatide at 84 wks (Reuters Feb 2026) Tirzepatide (Zepbound) Semaglutide alone (Wegovy) Cagrilintide alone These compounds are not interchangeable
Volume CAGR of 23.95% for the GLP-1/GIP segment through 2031 partly reflects the anticipated expansion driven by oral formulations reaching price-sensitive and needle-averse populations globally
How to Submit Claims with J-Codes
Why Patients Choose Maho Health Clinic Over IV Therapy Clinics
Pricing varies based on your personalized plan
